Non-Communicable Disease Burden in Syria: A Cross-Sectional Study of Internal Medicine Challenges, Trends, and Prospects
Abstract
Keywords
Full Text:
PDFReferences
REFERENCES
World Health Organization. Noncommunicable diseases [Internet]. Geneva: WHO; 2024 [cited 2025 Apr 1]. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
GBD 2021 Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10434):2129–74.
Rastam S, Al Ali R, Maziak W, et al. Forecasting future prevalence of type 2 diabetes mellitus in Syria. BMC Public Health. 2013;13:507.
Maziak W, Taleb ZB, Bahelah R, et al. The global epidemiology of waterpipe smoking. Tob Control. 2015;24(Suppl 1):i3–12.
United Nations High Commissioner for Refugees (UNHCR). Syria Emergency [Internet]. Geneva: UNHCR; 2024 [cited 2025 Mar 15]. Available from: https://www.unhcr.org/syria-emergency.html
World Health Organization, Regional Office for the Eastern Mediterranean. Syrian Arab Republic: Public Health Situation Analysis (PHSA). Cairo: WHO EMRO; 2022.
Garry S, Pringle J, Almustafa M, et al. Access to essential medicines for noncommunicable diseases during conflicts: The case of cardiovascular diseases, diabetes and epilepsy in Northern Syria. PLoS One. 2025 [Epub ahead of print].
Akik C, Ghattas H, Mesmar S, et al. Host country responses to non-communicable diseases amongst Syrian refugees: a systematic review. Confl Health. 2019;13:8.
Naja F, Shatila H, El Koussa M, Meho L, Ghandour L, Saleh S. Burden of non-communicable diseases among Syrian refugees: a scoping review. BMC Public Health. 2019;19(1):637.
Al-Abdulla O, Alaref M, Kallström A, Kauhanen J. The health system in Syria (2000–2024): assembling the pieces of a fragmented system a scoping review. Health Res Policy Syst. 2025;23(1):85.
Al-Jumaili AA, Al-Jumaili MK, Al-Ani R, et al. The prevalence of non-communicable diseases among Syrian refugees in Syria’s neighbouring host countries: a systematic review and meta-analysis. Public Health. 2022;205:107–15.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22(3):276–82.
Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Internet]. Ottawa: Ottawa Hospital Research Institute; 2013 [cited 2025 Feb 10]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.
Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.
Furuya-Kanamori L, Barendregt JJ, Doi SAR. A new improved graphical and quantitative method for detecting bias in meta-analysis. Int J Evid Based Healthc. 2018;16(4):195–203.
Almansouri T, Alazraki M, Hayaly RI, Sinjab A, Akhras M, Marhoum El Filali K. Outpatient cardiovascular diseases and diabetes medicines dispensing in the population with government health insurance in Syria between 2018 and 2019: a retrospective analysis. BMC Health Serv Res. 2021;21(1):1009.
Abdo N, Almasaid S, Alhemedi AJ, et al. A nationwide comparative analysis of the prevalence and determinants of non-communicable diseases risk factors between Jordanian and displaced Syrian populations. BMC Public Health. 2025;25(1):1862.
International Diabetes Federation. IDF Diabetes Atlas, 10th edition [Internet]. Brussels: IDF; 2021 [cited 2025 Jan 20]. Available from: https://www.diabetesatlas.org
Alkurdi A, Alkurdi M, Alhamid M, et al. Prediabetes in Syria and its associated factors: a single-center cross-sectional study. BMC Endocr Disord. 2022;22(1):218.
Patel SA, Cunningham SA, Tandon N, Kinra S. Increments in metabolic and cardiovascular risk factors in South Asian populations: a structured review. J Prim Care Community Health. 2020;11:1–9.
Atabaki-Pasdar N, Ohlsson M, Viby-Mogensen J, et al. Predicting and elucidating the etiology of fatty liver disease: a machine learning modeling and validation study. PLoS Med. 2020;17(6):e1003149. [Cited here as representative cardiometabolic risk study.]
Alhouri A, Albawab N, Albawab K, et al. Syrians’ awareness of cardiovascular disease risk factors and warning indicators: a descriptive cross-sectional study. Sci Rep. 2023;13(1):6562.
Khalil AH, Haddad H, Alia M, et al. Assessment of awareness toward hypertension and diabetes mellitus: Syrian cross-sectional study. BMC Public Health. 2023;23(1):786.
Garry S, Abebe R, Blanchet K, et al. Clinical outcomes in a primary-level non-communicable disease programme for Syrian refugees and the host population in Jordan: a cohort analysis using routine data. PLoS Med. 2021;18(1):e1003444.
Garry S, Abebe R, Kester J, et al. Delivering a primary-level non-communicable disease programme for Syrian refugees and the host population in Jordan: a descriptive costing study. Health Policy Plan. 2020;35(9):1168–78.
Albawab N, Junbolat B, Almohamad A, et al. Knowledge and awareness of type 2 diabetes complications in conflict-affected regions: a cross-sectional study in Homs, Syria. Cureus. 2024;16(9):e68686.
Budreviciute A, Damiati S, Sabir DK, et al. Management and prevention strategies for non-communicable diseases (NCDs) and their risk factors. Front Public Health. 2020;8:574111.
DOI: http://dx.doi.org/10.52155/ijpsat.v57.2.8186
Refbacks
- There are currently no refbacks.
Copyright (c) 2026 Abdulah Abou Kaff

This work is licensed under a Creative Commons Attribution 4.0 International License.

















